David Attwood
Director of Finance/CFO at THCinol/CBDinol CanPharma GmbH
David Attwood active positions
| Companies | Position | Start | End |
|---|---|---|---|
THCinol/CBDinol CanPharma GmbH
 THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | Director of Finance/CFO | - | - |
Career history of David Attwood
Former positions of David Attwood
| Companies | Position | Start | End |
|---|---|---|---|
| HEALTH HOUSE INTERNATIONAL | Chief Executive Officer | 2021-08-09 | 2023-03-18 |
Training of David Attwood
| The University of Nottingham | Graduate Degree |
| Instituto de Estudios Superiores de la Empresa | Masters Business Admin |
Statistics
International
| United Kingdom | 2 |
| Spain | 2 |
| Australia | 2 |
Operational
| Director of Finance/CFO | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Health House International Ltd.
 Health House International Ltd. Pharmaceuticals: OtherHealth Technology Health House International Ltd. engages in the distribution of medicinal cannabis. The company was founded by Jason Peterson and Harry Karelis in 2014 and is headquartered in Melbourne, Australia. | Health Technology |
THCinol/CBDinol CanPharma GmbH
THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | Health Technology |
- Stock Market
- Insiders
- David Attwood
- Experience
